Peter F Ehrlich1, Thomas E Hamilton2, Kenneth Gow3, Douglas Barnhart4, Fernando Ferrer5, Jessica Kandel6, Richard Glick7, Roshni Dasgupta8, Arlene Naranjo9, Ying He10, Elizabeth J Perlman11, John A Kalapurakal11, Geetika Khanna12, Jeffrey S Dome13, James Geller8, Elizabeth Mullen2. 1. C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, Michigan. pehrlich@med.umich.edu. 2. Dana Farber Cancer Institute, Boston Children's Hospital, Boston, Michigan. 3. Seattle Children's Hospital, Seattle, Washington. 4. Primary Children's Medical Center, Salt Lake, Utah. 5. Connecticut Children's Hospital, Hartford, Connecticut. 6. Comer Children's Hospital University of Chicago, Chicago, Illinois. 7. Steven and Alexandra Cohen Medical Center of New York, New York, New York. 8. Cincinnati Children's Hospital, Cincinnati, Ohio. 9. Children's Oncology Group (COG) Statistics and Data Center (SDC), University of Florida, Gainesville, Florida. 10. Department of Mathematics, Clarkson University, Potsdam, New York. 11. Luire Children's Hospital Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 12. Department of Radiology, Washington University School of Medicine, St Louis, Missouri. 13. Children's National Medical Center, Washington, District of Columbia.
Abstract
BACKGROUND: The purpose of this study was to evaluate the frequency and characteristics of surgical protocol violations (SPVs) among children undergoing surgery for renal tumors who were enrolled on the Children's Oncology Group (COG) renal tumor biology and classification study AREN03B2. METHODS: AREN03B2 was opened in February 2006, and as on March 31, 2013, there were 3,664 eligible patients. The surgical review forms for 3,536 patients with unilateral disease were centrally reviewed for SPVs. The frequency, type, number of violations, institutional prevalence, and quartiles for SPVs were assessed. RESULTS: Of the 3,536 patients, there were a total of 505 with at least one SPV (564 total SPVs reported), for an overall incidence of 14.28%. The types of SPVs included a lack of lymph node sampling in 365 (64.7%), avoidable spill in 61 (10.8%), biopsy immediately before nephrectomy in 89 (15.8%), an incorrect abdominal incision in 32 (5.7%), and unnecessary resection of organs in 17 (3.0%). The SPVs occurred in 163 of 215 participating institutions (75.8%). For centers with at least one SPV, the mean number of SPVs reported was 3.10 ± 2.39 (mean ± standard deviation). The incidence of protocol violation per institution ranged from 0 to 67%. Centers with an average of ≤1 case/year had an incidence of SPVs of 12.2 ± 3.8%, those with an average of >1 to <4 cases/year had an incidence of SPVs of 16.4 ± 3.6%, and those with an average of ≥4 cases/year had an incidence of SPVs of 12.6 ± 5.5% (P > 0.05). CONCLUSIONS: SPVs that potentially result in additional exposure to chemotherapy and radiation therapy are not uncommon in children undergoing resection of renal malignancies.
BACKGROUND: The purpose of this study was to evaluate the frequency and characteristics of surgical protocol violations (SPVs) among children undergoing surgery for renal tumors who were enrolled on the Children's Oncology Group (COG) renal tumor biology and classification study AREN03B2. METHODS: AREN03B2 was opened in February 2006, and as on March 31, 2013, there were 3,664 eligible patients. The surgical review forms for 3,536 patients with unilateral disease were centrally reviewed for SPVs. The frequency, type, number of violations, institutional prevalence, and quartiles for SPVs were assessed. RESULTS: Of the 3,536 patients, there were a total of 505 with at least one SPV (564 total SPVs reported), for an overall incidence of 14.28%. The types of SPVs included a lack of lymph node sampling in 365 (64.7%), avoidable spill in 61 (10.8%), biopsy immediately before nephrectomy in 89 (15.8%), an incorrect abdominal incision in 32 (5.7%), and unnecessary resection of organs in 17 (3.0%). The SPVs occurred in 163 of 215 participating institutions (75.8%). For centers with at least one SPV, the mean number of SPVs reported was 3.10 ± 2.39 (mean ± standard deviation). The incidence of protocol violation per institution ranged from 0 to 67%. Centers with an average of ≤1 case/year had an incidence of SPVs of 12.2 ± 3.8%, those with an average of >1 to <4 cases/year had an incidence of SPVs of 16.4 ± 3.6%, and those with an average of ≥4 cases/year had an incidence of SPVs of 12.6 ± 5.5% (P > 0.05). CONCLUSIONS: SPVs that potentially result in additional exposure to chemotherapy and radiation therapy are not uncommon in children undergoing resection of renal malignancies.
Authors: Daniel M Green; Jane M Lange; Eve M Peabody; Natalia N Grigorieva; Susan M Peterson; John A Kalapurakal; Norman E Breslow Journal: J Clin Oncol Date: 2010-05-10 Impact factor: 44.544
Authors: John D Birkmeyer; David M Shahian; Justin B Dimick; Samuel R G Finlayson; David R Flum; Clifford Y Ko; Bruce Lee Hall Journal: J Am Coll Surg Date: 2008-09-19 Impact factor: 6.113
Authors: Shahid Shafi; Avery B Nathens; H Gill Cryer; Mark R Hemmila; Michael D Pasquale; David E Clark; Melanie Neal; Sandra Goble; J Wayne Meredith; John J Fildes Journal: J Am Coll Surg Date: 2009-08-13 Impact factor: 6.113
Authors: D M Green; Y A Grigoriev; B Nan; J R Takashima; P A Norkool; G J D'Angio; N E Breslow Journal: J Clin Oncol Date: 2001-04-01 Impact factor: 44.544
Authors: Grace L Smith; Ying Xu; Ya-Chen T Shih; Sharon H Giordano; Benjamin D Smith; Kelly K Hunt; Eric A Strom; George H Perkins; Gabriel N Hortobagyi; Thomas A Buchholz Journal: J Am Coll Surg Date: 2009-08-20 Impact factor: 6.113
Authors: David B Dix; Nita L Seibel; Yueh-Yun Chi; Geetika Khanna; Eric Gratias; James R Anderson; Elizabeth A Mullen; James I Geller; John A Kalapurakal; Arnold C Paulino; Elizabeth J Perlman; Peter F Ehrlich; Marcio Malogolowkin; Julie M Gastier-Foster; Elizabeth Wagner; Paul E Grundy; Conrad V Fernandez; Jeffrey S Dome Journal: J Clin Oncol Date: 2018-04-16 Impact factor: 44.544
Authors: David B Dix; Conrad V Fernandez; Yueh-Yun Chi; Elizabeth A Mullen; James I Geller; Eric J Gratias; Geetika Khanna; John A Kalapurakal; Elizabeth J Perlman; Nita L Seibel; Peter F Ehrlich; Marcio Malogolowkin; James Anderson; Julie Gastier-Foster; Robert C Shamberger; Yeonil Kim; Paul E Grundy; Jeffrey S Dome Journal: J Clin Oncol Date: 2019-08-26 Impact factor: 44.544
Authors: Alonso Carrasco; Brian T Caldwell; Carrye R Cost; Brian S Greffe; Timothy P Garrington; Jennifer L Bruny; Jennifer O Black; Nicholas G Cost Journal: Pediatr Blood Cancer Date: 2017-01-18 Impact factor: 3.167
Authors: Jesse K Sandberg; Elizabeth A Mullen; Mariana M Cajaiba; Ethan A Smith; Sabah Servaes; Elizabeth J Perlman; James I Geller; Peter F Ehrlich; Nicholas G Cost; Jeffrey S Dome; Conrad V Fernandez; Geetika Khanna Journal: Pediatr Radiol Date: 2017-07-08